In conjunction with today’s launch of BioSolve Process 5, we have developed a whitepaper that demonstrates the significant savings that can be achieved by biopharma innovators in monoclonal antibody manufacture. The study used BioSolve Process to evaluate three different development scenarios: Current stainless steel technology
Biopharm is set to present a session entitled Assessing Innovation Across the Enterprise at this IChemE event on May 15, 2014. See www.techtransfer.co.uk for more info.
This week, Biopharm is chairing a panel on “Continuous Processing and Closed Cystems” at the 2014 BioProcess International Europe Summit in Prague. The summit reflects on the critical challenges facing the production, analysis and formulation of biologics. This meeting congregates top industry speakers in 5
This week, Biopharm is delivering a presentation at PDA Europe’s Modern Biopharmaceutical Manufacturing conference in Lyon, France. The presentation is entitled “Continuous Manufacturing, an Overview. Cost Drivers, Facility Impact, Quality Implications.” With a focus on the regulatory and quality aspects of biopharmaceutical production, this annual
This week, Biopharm is hosting a roundtable at Cell Culture World Congress, in Munich, Germany. Cell Culture World Congress is where all major existing and emerging players obtain practical and technical outcomes to upstream and scale-up. For more information, click here.
This week, Biopharm will be attending “Biopharmaceutical Innovation, a Vision for the Future” in London. The 10th Annual annual bioProcessUK Conference 2013 has become the UK’s leading technical networking meeting for professionals developing biological medicines. For more information, click here.
Biopharm will today deliver a presentation on Innovation at the IChemE Thames Valley Biotechnology Showcase. This year’s Biotechnology Showcase once again brings together the leading bioprocess companies in the area. The presentations give local engineers the opportunity to understand more about the companies, as well
This week at the ISPE Biotechnology conference in Strasbourg, Biopharm will deliver a joint presentation entitled “Key Challenges/Barriers to Further Implementation of Disposable Technologies”. One of the biggest challenges or barriers to further disposables implementation today is the lack of harmonised industry standards whether it
